Work

Single-center experience with sasi bypass: mid-term outcomes and technical evolution

Year: 2026
Type: article
Study design: Observational Study
Abstract: To evaluate the feasibility, safety, and metabolic outcomes of the Single Anastomosis Sleeve Ileal (SASI) bypass in patients undergoing primary metabolic and bariatric surgery at our institution, expanding upon previous data. A retrospective cohort study was conducted including patients who underwent SASI bypass as a primary procedure. Primary outcomes included %EWL and remission rates of T2DM, hypertension, dyslipidemia, and other obesity-related diseases. Complications were classified using the Clavien–Dindo system. Surgical technique modifications were analyzed for their impact on outcomes. A subset of patients was followed for more than three years, allowing mid-term outcome evaluation. Mean %TWL 33.0%. Remission rates for T2DM, hypertension, and dyslipidemia were 78.3%, 89.1%, and 85.6%, respectively. GERD symptoms improved in all affected patients, with 57.9% achieving complete remission. The overall complication rate was 13.1%, with a 3.6% reoperation rate, and most adverse events occurred early in the study period. Technical modifications, including reduction of anastomosis size and adjustment of limb length, were associated with lower %EWL but decreased complication rates. SASI bypass is a safe and effective metabolic procedure, demonstrating encouraging outcomes in weight loss and diabetes remission, with emerging evidence of GERD improvement. Anastomosis size (≤ 2.5–3 cm) and alimentary limb length (≈ 3–3.5 m) are key factors in balancing efficacy and nutritional risk. Further studies are needed to define the optimal configuration and long-term outcomes.
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,590
OpenAlex ID: W7164008909
FWCI:
Cites: 23
Cited by:
Related to: 10